Analyst Ratings for Ionis Pharmaceuticals (IONS) [Buys]

IONS Rating Summary

IONS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IONS
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $59.04 (+64.2%) * Over Last 12-Mos
Rating Score: 4 / 10   Percentile Rank: 37%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/15/2020 Cowen Yaron Werber Upgrade Outperform
(Market Perform)
N/A
(N/A)
47.83
(35.96)
-24.82% Details
6/1/2020 Oppenheimer
» Updated 3/23/2021
Kevin DeGeeter New Coverage Outperform
(N/A)
63.00
(N/A)
56.21
(35.96)
-36.03% Details
Like IONS Ratings? Also take a look at AKCA, BIIB, ACCD, PFE

IONS Ratings News